Gritstone bio Inc at Goldman Sachs Healthcare Conference Transcript
Well, great. Thanks so much for joining us today. We have Gritstone bio and Celia here to join us, who's the CFO for the company.
Questions & Answers
And maybe Celia, you could just start with like a brief overview, particularly focused on what you see as key value drivers for the company for the next 12 to 24 months.
Of course. Well, it's good to be here, Corinne, in such a packed room at the end of the day, tons and tons of people in here. Thank you for the invitation, first and foremost. We're pleased to be here after quite a few years of not really having this conference. So Gritstone is in a pretty amazing spot right now. We have a pretty major catalyst that's coming up in Q1 of next year for our lead program, GRANITE, which is a personalized neoantigen-based cancer vaccine. We've been hearing a lot
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |